Literature DB >> 16273779

OMERACT: an international initiative to improve outcome measurement in rheumatology.

M Boers1, P Brooks, L S Simon, V Strand, P Tugwell.   

Abstract

OMERACT is the acronym for an international, informally organized network aimed at improving outcome measurement in rheumatology. Chaired by an executive committee it organizes consensus conferences in a 2-yearly cycle that circles the globe since 2002. Data driven recommendations are prepared and updated by expert working groups. Recommendations include core sets of measures for most of the major rheumatologic conditions. Since 2002 patients have been actively engaged in the process. OMERACT 8 will take place in Malta, May 2006 (www.omeract.org).

Entities:  

Mesh:

Year:  2005        PMID: 16273779

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  13 in total

1.  Development of responder definitions for fibromyalgia clinical trials.

Authors:  Lesley M Arnold; David A Williams; James I Hudson; Susan A Martin; Daniel J Clauw; Leslie J Crofford; Fujun Wang; Birol Emir; Chinglin Lai; Rong Zablocki; Philip J Mease
Journal:  Arthritis Rheum       Date:  2012-03

Review 2.  Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.

Authors:  Dinesh Khanna; Daniel E Furst; Yannick Allanore; Sangmee Bae; Vijay Bodukam; Philip J Clements; Maurizio Cutolo; Laszlo Czirjak; Christopher P Denton; Oliver Distler; Ulrich A Walker; Marco Matucci-Cerinic; Ulf Müller-Ladner; James R Seibold; Manjit Singh; Alan Tyndall
Journal:  Rheumatology (Oxford)       Date:  2014-08-13       Impact factor: 7.580

3.  Developing a Core Set to describe functioning in vocational rehabilitation using the international classification of functioning, disability, and health (ICF).

Authors:  Reuben Escorpizo; Jan Ekholm; Hans-Peter Gmünder; Alarcos Cieza; Nenad Kostanjsek; Gerold Stucki
Journal:  J Occup Rehabil       Date:  2010-12

4.  Clinical and ultrasound evaluation of the response to tocilizumab treatment in patients with rheumatoid arthritis: a case series.

Authors:  Oscar Epis; Emilio Filippucci; Andrea Delle Sedie; Anna De Matthaeis; Eleonora Bruschi
Journal:  Rheumatol Int       Date:  2013-01-26       Impact factor: 2.631

Review 5.  Do patients have a say? A narrative review of the development of patient-reported outcome measures used in elective procedures for coronary revascularisation.

Authors:  Geeske Peeters; Anna L Barker; Jason Talevski; Ilana Ackerman; Darshini R Ayton; Christopher Reid; Sue M Evans; Johannes U Stoelwinder; John J McNeil
Journal:  Qual Life Res       Date:  2018-01-29       Impact factor: 4.147

6.  The degree of cartilage degradation assessed by serum biomarker levels changes after arthroscopic knee synovectomy in rheumatoid arthritis patients.

Authors:  Marina Lipina; Maxim Makarov; Sergey Makarov; Alexander Novikov
Journal:  Int Orthop       Date:  2017-09-09       Impact factor: 3.075

Review 7.  Bisphosphonate therapy for children and adolescents with secondary osteoporosis.

Authors:  L Ward; A C Tricco; P Phuong; A Cranney; N Barrowman; I Gaboury; F Rauch; P Tugwell; D Moher
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

8.  Outcomes in registered, ongoing randomized controlled trials of patient education.

Authors:  Cécile Pino; Isabelle Boutron; Philippe Ravaud
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

9.  Research priorities for non-pharmacological therapies for common musculoskeletal problems: nationally and internationally agreed recommendations.

Authors:  Nadine E Foster; Krysia S Dziedzic; Danielle A W M van der Windt; Julie M Fritz; Elaine M Hay
Journal:  BMC Musculoskelet Disord       Date:  2009-01-09       Impact factor: 2.362

10.  An internet survey of 2,596 people with fibromyalgia.

Authors:  Robert M Bennett; Jessie Jones; Dennis C Turk; I Jon Russell; Lynne Matallana
Journal:  BMC Musculoskelet Disord       Date:  2007-03-09       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.